Abstract: The present invention is directed to novel indazolyl-substituted pyrroline compounds of Formula (I): 1

Abstract: This invention is directed to macroheterocyclic compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.

Abstract: A biosensor for determining the concentration of an analyte in a biological sample. The biosensor comprises a support, a reference electrode or a counter electrode or both a reference and a counter electrode disposed on the support, a working electrode disposed on the support, the working electrode spaced apart from the other electrode or electrodes on the support, a covering layer defining a sample chamber over the electrodes, an aperture in the covering layer for receiving a sample, and at least one layer of mesh in the sample chamber between the covering layer and the electrodes. The at least one layer of mesh has coated thereon a silicone surfactant. Certain silicone surfactants are as effective as fluorinated surfactants with respect to performance of biosensors. These surfactants, when coated onto the mesh layer of the biosensor, are effective in facilitating the transport of aqueous test samples, such as blood, in the sample chamber.

Abstract: A moisture curable composition capable of cure to an elastomeric body, comprising a polymeric material having not less than two hydroxyl or hydrolysable groups an alkoxysilane curative and a catalyst comprising:

Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.

Abstract: An ultrafast all-optical nonlinear switch. The switch has as components a substrate and a material disposed on the substrate. In one embodiment, the material includes a plurality of single-walled carbon nanotubes and a polymer forming a composite. Preferably, the polymer is polyimide. In another embodiment, the material includes a plurality of single-walled carbon nanotubes incorporated into a silica. The nanotube loading in the material is less than about 0.1 wt %. The material is a substantially transparent, third-order nonlinear optical material. The switch has a switching speed of less than 1 picosecond for light with a wavelength of about 1.55 micrometers. Also disclosed is a process for preparing the ultrafast all-optical nonlinear switch.

Abstract: The invention is directed to novel heteroaryl peptidomimetic compounds which are useful as thrombin receptor antagonists for the treatment of diseases associated with thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, angiogenesis and related disorders, cancer, and neurodegenerative disorders. Pharmaceutical compositions comprising the substituted heteroaryl peptidomimetics of the present invention and methods of treating conditions mediated by the thrombin receptor are also disclosed.

Abstract: The invention is directed to novel aminomethyl-pyrroloquinazoline compounds and pharmaceutical compositions thereof which are useful thrombin receptor or PAR-1 antagonists, methods for production thereof and methods for treating thrombin or PAR-1 mediated disorders.

Abstract: A method of improving spatial resolution of a pump-probe terahertz (THz) imaging system for producing an image of an object. The method provides a chopped optical gating beam focused on a semiconductive layer that is either part of the object or a discrete layer placed over the object. The gating beam is focused on a gating pulse focal spot having a diameter effective to cause measurable modulation in transmission of a THz beam through the semiconductive layer when the gating pulse is on as compared to when the gating pulse is off, creating alternating modulated THz beams for detection and processing. Systems for performing the method in transmission and reflection modes are also described.

Abstract: The invention is directed to novel benzimidazolone peptidomimetic compounds which are useful as thrombin receptor antagonists for the treatment of diseases associated with thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, Angiogenesis related disorders, cancer, and neurodegenerative disorders. Pharmaceutical compositions comprising the substituted benzimidazolone peptidomimetics of the present invention and methods of treating conditions mediated by the thrombin receptor are also disclosed.

Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.

Abstract: In a communication system, a subscriber unit includes a storage device storing an application program to determine for transmission a current reserved bandwidth and a transmission parameter based on a quality of based on a quality of service profile, and an adapter to communicate data over a wireless network (e.g., a general packet radio service network) that supports a service, satisfying a reliability requirement for the service. The adapter may dynamically adjust the transmission parameter for the transmission before retransmitting one or more packets of data, e.g., at a rate and retransmission times commensurate with the current reserved bandwidth, and the reliability requirement in addition to the a current quality of service profile, ensuring a service level which otherwise cannot be provided by an infrastructure negotiated quality of service, especially in relatively shorter flows of data.

Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.

Abstract: A method and apparatus for measuring electromagnetic pulses as a function of time. Radiation measurement, including measurement of single-shot, free-space terahertz femtosecond pulses, is realized using an electro-optical modulator in combination with an optical streak camera. This method and apparatus allow measurement of electromagnetic pulses previously unmeasurable due to the time resolution restrictions dictated by the time-frequency correlation.

Abstract: An organohybrid-based damping material for controlling unwanted vibration and noise, an organic damping improver exhibiting piezoelectric, dielectric and electroconductive effects, and their producing methods, are provided. The damping material comprises a polymer matrix having a polar side chain and a damping improver composed of a compound containing basic nitrogen and a phenol-based compound. The damping material shows an excellent damping properties, alleviates the functional deterioration, and is applicable to different application temperature regions and wide areas.

Abstract: Systems and methods for reconstructing a plurality of images of an object. An exemplary system includes a radiation source adapted to emit radiation at a plurality of frequencies; a lens with frequency-dependent focal length, such as a Fresnel lens, adapted to receive radiation modified by the object and to project onto a fixed image plane a frequency-dependent image of a slice of the object perpendicular to the radiation path; a sensor for capturing the frequency-dependent image of the object; and apparatus for facilitating creation and capture of a plurality of frequency-dependent images of the object at the plurality of frequencies. A system for reconstructing a tomographic image of the object further includes apparatus for assembling the plurality of frequency-dependent images to reconstruct the tomographic image. Methods and systems are described for use in the visible, audible, and THz frequency ranges and with broadband or narrowband radiation sources.

Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.

Abstract: The invention is directed to novel indole peptidomimetic compounds which are useful as thrombin receptor antagonists for the treatment of diseases associated with thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, Angiogenesis related disorders, cancer, and neurodegenerative disorders. Pharmaceutical compositions comprising the substituted indole peptidomimetics of the present invention and methods of treating conditions mediated by the thrombin receptor are also disclosed.

Abstract: Polymers containing polyene-bridged second-order nonlinear optical chromophores and devices incorporating the same are disclosed. The chromophores are functionalized and incorporated into a series of polymers ranging from linear polyesters, linear poly[ester-imide]s, chain-crosslinked polyesters/poly[ester-imide]s, to crosslinked star-shaped/dendritic macromolecules. An exemplary preferred polymer is a linear chain polymer formed from a dihydroxy-functionalized polyene-bridged chromophore, a diacid or diacid dichloride, and a diol. In a preferred embodiment, the diol structure also includes at least one imide group. Another exemplary preferred polymer is a crosslinked polymer comprised of a linear chain polymer formed from a dihydroxy-functionalized polyene-bridged chromophore, a diacid or diacid dichloride and a diol.

Abstract: The invention is directed to novel indazole peptidomimetic compounds which are useful as thrombin receptor antagonists for the treatment of diseases associated with thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, Angiogenesis related disorders, cancer, and neurodegenerative disorders. Pharmaceutical compositions comprising the substituted indazole peptidomimetics of the present invention and methods of treating conditions mediated by the thrombin receptor are also disclosed.